Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Harvard Business School
Farmers Insurance
Chinese Patent Office
Dow
Cerilliant
Cipla
Cantor Fitzgerald

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 083329

« Back to Dashboard

NDA 083329 describes CHLORPROMAZINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Pharm Assoc, Wockhardt, Abraxis Pharm, Marsam Pharms Llc, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Alpharma Us Pharms, Abbott, Cycle Pharms Ltd, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Purepac Pharm, Pvt Form, Sandoz, Usl Pharma, Vangard, and West Ward, and is included in fifty-four NDAs. It is available from twelve suppliers. Additional details are available on the CHLORPROMAZINE HYDROCHLORIDE profile page.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.
Summary for 083329
Tradename:CHLORPROMAZINE HYDROCHLORIDE
Applicant:West-ward Pharms Int
Ingredient:chlorpromazine hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 083329
Ingredient-typePhenothiazines
Suppliers and Packaging for NDA: 083329
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride INJECTABLE;INJECTION 083329 ANDA West-Ward Pharmaceuticals Corp. 0641-1397 N 0641-1397-35
CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride INJECTABLE;INJECTION 083329 ANDA West-Ward Pharmaceuticals Corp. 0641-1398 N 0641-1398-35

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength25MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
McKinsey
Daiichi Sankyo
Argus Health
Cipla
US Army
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.